MedPath

Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)

Not Applicable
Recruiting
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
Procedure: Systematically mediastinal lymph node dissection
Procedure: No mediastinal lymph node dissection
First Posted Date
2020-08-26
Last Posted Date
2023-07-20
Lead Sponsor
Fudan University
Target Recruit Count
638
Registration Number
NCT04527419
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, China

The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients

Conditions
Liver Metastases
Colorectal Cancer
First Posted Date
2020-08-25
Last Posted Date
2020-08-25
Lead Sponsor
Fudan University
Target Recruit Count
116
Registration Number
NCT04525313

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Phase 3
Conditions
Colorectal Cancer
Liver Metastases
Interventions
Drug: Cetuximab
Drug: Bevacizumab
Drug: mFOLFOX/FOLFIRI ( Standard Chemotherapy)
First Posted Date
2020-08-25
Last Posted Date
2020-08-25
Lead Sponsor
Fudan University
Target Recruit Count
584
Registration Number
NCT04525326

Precision Medicine for Colorectal Cancer Liver Metastasis Guided by Multi-omics Data Under the Umbrella Theory

Conditions
Colorectal Cancer Metastatic
Interventions
Diagnostic Test: Multi-omics
First Posted Date
2020-08-25
Last Posted Date
2020-08-25
Lead Sponsor
Fudan University
Target Recruit Count
200
Registration Number
NCT04525807

Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study

Phase 2
Conditions
Thyroid Cancer
Interventions
First Posted Date
2020-08-24
Last Posted Date
2020-08-24
Lead Sponsor
Fudan University
Target Recruit Count
10
Registration Number
NCT04524884
Locations
🇨🇳

270 Dongan Road, Fudan University Shanghai Cancer Center, Shanghai, China

Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell

Phase 2
Conditions
PFS
Interventions
Drug: camrelizumab
Drug: Paclitaxel
Drug: Neoadjuvant Chemotherapy
First Posted Date
2020-08-20
Last Posted Date
2020-08-20
Lead Sponsor
Fudan University
Target Recruit Count
60
Registration Number
NCT04520035
Locations
🇨🇳

Cancer hospital Fudan University, Shanghai, Xuhui, China

Laparoscopic Sleeve Gastrectomy Under General Anesthesia in Severely Obese Patients: a Retrospective Study

Conditions
Obesity
First Posted Date
2020-08-20
Last Posted Date
2020-08-20
Lead Sponsor
Fudan University
Target Recruit Count
100
Registration Number
NCT04521543
Locations
🇨🇳

Zhongshan Hospital Fudan University, Shanghai, Shanghai, China

Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)

Phase 3
Recruiting
Conditions
Ovarian Cancer
Interventions
Drug: Etoposide, Cyclophosphamide, Carboplatin/Cisplatin
First Posted Date
2020-08-20
Last Posted Date
2022-07-27
Lead Sponsor
Fudan University
Target Recruit Count
590
Registration Number
NCT04520074
Locations
🇨🇳

Wu Xiaohua, Shanghai, Shanghai, China

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

Not Applicable
Recruiting
Conditions
Esophageal Squamous Cell Carcinoma
Chemoradiotherapy
Survival
Interventions
Drug: Paclitaxel plus carboplatin
Radiation: radiotherapy
First Posted Date
2020-08-20
Last Posted Date
2021-11-02
Lead Sponsor
Fudan University
Target Recruit Count
320
Registration Number
NCT04519905
Locations
🇨🇳

Fudan Universtiy Shanghai Cancer Center, Shanghai, Shanghai, China

🇨🇳

Huadong Hospital, Shanghai, Shanghai, China

🇨🇳

Jiangsu Cancer Hospital, Nanjing, Jiangsu, China

Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer

Phase 2
Active, not recruiting
Conditions
Thyroid Cancer
Interventions
Drug: multiple tyrosine kinase inhibitor(mTKI) Combined with anti-PD-1 antibody
First Posted Date
2020-08-20
Last Posted Date
2023-12-21
Lead Sponsor
Fudan University
Target Recruit Count
115
Registration Number
NCT04521348
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath